rs542967227
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PP2PP3PP5_Very_Strong
The NM_000128.4(F11):c.1432G>A(p.Gly478Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000545 in 1,614,162 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000128.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital factor XI deficiencyInheritance: AD, AR, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152174Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000103 AC: 26AN: 251454 AF XY: 0.000103 show subpopulations
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary factor XI deficiency disease Pathogenic:9
- -
- -
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with factor XI deficiency. Dominant negative missense variants tend to have dominant inheritance patterns (PMID:15026311), while loss of function variants are generally recessive, though symptomatic carriers have been reported (OMIM). (I) 0108 - This gene is associated with both recessive and dominant disease. Recessive cases are more severe than cases involving heterozygous carriers, who may be asymptomatic despite having FXI deficiency (PMID:18446632). (I) 0115 - Variants in this gene are known to have variable expressivity. There is a high degree of variable expression. Intrafamilial variation has been reported (PMID: 32118380). (I) 0200 - Variant is predicted to result in a missense amino acid change from glycine to arginine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 (v2: 26 heterozygotes, 0 homozygote). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated Trypsin domain (DECIPHER). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. Also known as Gly460Arg, this variant has been reported multiple times pathogenic in ClinVar, and in the literature in individuals with Factor XI deficiency including at least one heterozygous individual (PMID: 15842381, 27710856, 16835901, 16079124). (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
The p.Gly478Arg ( historically referred to as Gly460Arg) variant in F11 has been reported in at least 5 homozygous, 2 compound heterozygous, and 2 heterozygous individuals with Hereditary factor XI deficiency disease. Majority of these individuals were noted to have reduced FXI:C and/or FXI:Ag levels (Mitchell 2003 PubMed: 12716376; Saunders 2009 PubMed: 19652879; Downes 2019 PubMed: 31064749; Jayandharan 2005 PMID: 15842381; Mitchell 2006 PMID: 16835901; Pike 2016 PMID: 26558335). It was also observed in ClinVar (Variation ID 285379) and in 0.14% (7/4828) of South Asian gnomAD (http://gnomad.broadinstitute.org). Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Hereditary factor XI deficiency disease; although, some heterozygotes may present with features. ACMG/AMP Criteria applied: PM3_VeryStrong, PP3, PP4. -
- -
- -
The missense c.1432G>A (p.Gly478Arg) variant in the F11 gene has been observed in individuals with factor XI (FXI) deficiency (Mitchell, Michael et al.,2006). It has also been observed to segregate with disease in related individuals. This variant is reported with the allele frequency (0.01%) in the gnomAD Exomes and novel in 1000. It is submitted to ClinVar as Pathogenic/Likely Pathogenic. The amino acid Glycine at position 478 is changed to a Arginine changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Gly478Arg in F11 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
not provided Pathogenic:2
- -
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 478 of the F11 protein (p.Gly478Arg). This variant is present in population databases (rs542967227, gnomAD 0.07%). This missense change has been observed in individuals with autosomal recessive factor XI (FXI) deficiency and/or factor XI (FXI) deficiency (PMID: 15842381, 16079124, 16835901, 19652879, 26558335). It has also been observed to segregate with disease in related individuals. This variant is also known as Gly460Arg. ClinVar contains an entry for this variant (Variation ID: 285379). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on F11 protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Plasma factor XI deficiency Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at